UL Solutions Inc ULS 深 沪
等待开盘 08-05 09:30:00 美东时间
73.04
+1.140
+1.59%
华盛通- 最 高73.34
- 今 开71.32
- 成交量 101.21万股
- 最 低 71.32
- 昨 收 71.90
- 总市值 146.08亿
- 52周最高 74.15
- 市盈率 静 44.85
- 换手率 0.51%
- 52周最低 46.405
- 委 比 93.16%
- 总股本 2.00亿
- 历史最高 74.15
- 量 比 1.43
- 振 幅 2.81%
- 历史最低 32.515
- 每 手 1
- 风险率 8.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多UL Solutions Launches Certification Programs For Battery Containment Enclosures And Micromobility Charging Equipment To Enhance Lithium-Ion Battery Safety And Prevent Thermal Runaway
UL Solutions' new battery containment enclosure and micromobility charging equipment certification programs help address growing concerns and incidents around lithium-ion battery safety risks and thermal runaway
06-19 18:48
UL Solutions declares $0.13 dividend
UL Solutions (NYSE:ULS) declares $0.13/share quarterly dividend, in line with previous. Forward yield 0.72% Payable June 9; for shareholders of record May 30; ex-div May 30. See ULS Dividend Scorecard...
05-21 12:47
美股大行评级 | 潜在涨幅105.34%！Amylyx Pharmaceuticals获Leerink Partners升目标价至10美元，上调至"跑赢大市"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
05-08 08:45
Wells Fargo Maintains Overweight on UL Solutions, Raises Price Target to $77
Wells Fargo analyst Jason Haas maintains UL Solutions (NYSE:ULS) with a Overweight and raises the price target from $65 to $77.
05-07 22:02
美股大行评级 | 潜在涨幅53%！HIMS获机构上调目标价至61美元，维持“买入”评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101427780957868033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持MiNK Therapeutics(INKT)"买入"评级，目标价从9美元升至35美元</p> <p>• D. Boral Capital：维持FiscalNote Ho
02-26 09:46
美股大行评级 | 潜在涨幅75%！Solar Edge获高盛升目标价至31美元，维持买入评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1099980218194210816.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：维持Chemomab Therapeutics(CMMB)"买入"评级，目标价从4美元升至7美元</p> <p>• Citizens Capital Markets：维持德纳维制药(DVAX)"跑赢
02-24 11:50
Earnings Scheduled For February 20, 2025
Companies Reporting Before The Bell • Idacorp (NYSE:IDA) is likely to report qu...
02-20 16:32
